Segment Category

Sub-Segments

Key Insights

By Type

• Electrochemical Sensing SoCs

• Optical Sensing SoCs

• Hybrid Multi‑Modal SoCs

• Lab‑on‑Chip Integrated SoCs

Electrochemical Sensing SoCs represent the leading segment within the type classification, driven by their superior compatibility with a broad range of biological analytes and their inherent suitability for miniaturized, low‑power diagnostic platforms.

• Electrochemical SoCs offer highly reliable signal transduction for detecting metabolic markers and infectious agents, making them the preferred architecture for glucose monitoring, cardiac biomarker detection, and immunoassay‑based rapid tests.

• Their ability to interface seamlessly with microfluidic cartridges and biosensor arrays positions them as the core technology underpinning next‑generation portable diagnostic readers used across clinical and non‑clinical settings.

• Continuous advancements in low‑noise analog front‑end circuitry and MEMS biosensor integration within electrochemical SoC platforms are enhancing sensitivity and selectivity, further consolidating their market‑leading position against optical and hybrid alternatives.

By Application

• Infectious Disease Diagnostics

• Chronic Disease Monitoring

• Emergency and Critical Care Diagnostics

• Oncology Biomarker Detection

• Others

Infectious Disease Diagnostics dominates the application landscape, propelled by persistent global demand for rapid, accurate identification of bacterial, viral, and parasitic infections at the point of patient care.

• The sustained global burden of respiratory infections, sexually transmitted diseases, and emerging epidemic threats continues to drive procurement of POC diagnostic reader platforms embedded with advanced SoC architectures capable of delivering near‑instantaneous results without laboratory infrastructure.

• Integration of AI‑enabled embedded processing within infectious disease‑focused SoCs is enabling multi‑pathogen detection from a single sample, reducing the diagnostic turnaround time and improving clinical decision‑making in resource‑constrained environments.

• Expanding healthcare access initiatives in developing regions, coupled with the proliferation of community health worker programs, are accelerating deployment of SoC‑powered infectious disease readers beyond traditional clinical settings into field and remote care environments.

By End User

• Hospitals and Clinics

• Home Care and Self‑Testing

• Diagnostic Laboratories

• Ambulatory and Emergency Care Centers

Hospitals and Clinics constitute the leading end‑user segment, as they represent the primary institutional environments where decentralized diagnostic capabilities are being most rapidly integrated into existing clinical workflows.

• The shift toward patient‑centric care models within hospital settings is encouraging procurement of SoC‑powered POC readers that can deliver real‑time biomarker analysis at the bedside, in emergency departments, and within outpatient consultation rooms, thereby reducing dependency on centralized laboratory processing.

• Hospitals are increasingly adopting connected POC diagnostic platforms that incorporate wireless communication modules within the SoC architecture, enabling seamless integration with electronic health record systems and facilitating remote monitoring of patient diagnostic data by clinical teams.

• Growing investments in hospital infrastructure modernization across both developed and emerging economies are further driving the adoption of advanced POC diagnostic reader SoCs as standard components of clinical diagnostic equipment portfolios.

By Connectivity Technology

• Bluetooth‑Enabled SoCs

• Wi‑Fi Integrated SoCs

• NFC‑Based SoCs

• Standalone Non‑Connected SoCs

Bluetooth‑Enabled SoCs lead the connectivity technology segment, reflecting the broad industry preference for low‑energy wireless transmission protocols that align with the power management constraints inherent to portable POC diagnostic reader devices.

• The prevalence of Bluetooth Low Energy (BLE) modules integrated within diagnostic SoC architectures enables seamless pairing with smartphones and tablets, allowing patients and clinicians to view, store, and share diagnostic results through dedicated mobile health applications without the need for complex infrastructure.

• As telehealth platforms and remote patient monitoring ecosystems continue to expand globally, Bluetooth‑enabled POC diagnostic readers are emerging as critical data acquisition nodes that feed real‑time clinical data into cloud‑connected health management systems, enhancing longitudinal disease monitoring capabilities.

• Leading semiconductor manufacturers are increasingly embedding multi‑protocol connectivity stacks-supporting both Bluetooth and NFC simultaneously-within single SoC packages, enabling greater device versatility while maintaining compact form factors suited for wearable and handheld diagnostic applications.

By Processing Architecture

• AI‑Embedded Processing SoCs

• Standard Microcontroller‑Based SoCs

• FPGA‑Integrated SoCs

AI‑Embedded Processing SoCs represent the fastest‑growing and increasingly dominant segment within the processing architecture category, as the integration of machine learning inference engines within POC diagnostic chipsets transforms the analytical capabilities of portable diagnostic readers.

• On‑device AI processing within diagnostic SoCs enables real‑time pattern recognition across complex biosensor signal outputs, significantly improving the accuracy of biomarker quantification and reducing the incidence of false positives and negatives that can adversely impact clinical decision‑making in time‑sensitive care environments.

• The incorporation of neural processing units and edge AI accelerators into diagnostic SoC architectures is enabling next‑generation POC readers to perform multi‑analyte simultaneous detection and adaptive noise filtering without reliance on cloud‑based computing resources, making them highly suitable for deployment in low‑connectivity rural and field settings.

• Semiconductor manufacturers specializing in embedded biosensing solutions are actively expanding their AI‑capable SoC portfolios to address growing demand from medical device OEMs seeking differentiated diagnostic platforms with intelligent data interpretation capabilities built directly into the hardware layer.